Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-21-009537
Filing Date
2021-07-29
Accepted
2021-07-29 06:10:23
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 6-K arg-20210630x6k.htm 6-K 34186
2 EX-99.1 arg-20210630ex991322ce4.htm EX-99.1 136391
3 EX-99.2 arg-20210630xex9924b519a.htm   iXBRL EX-99.2 1028250
4 GRAPHIC arg-20210630ex991322ce4001.jpg GRAPHIC 50700
  Complete submission text file 0001558370-21-009537.txt   4276086

Data Files

Seq Description Document Type Size
5 EX-101.SCH arg-20210630.xsd EX-101.SCH 49475
6 EX-101.CAL arg-20210630_cal.xml EX-101.CAL 59851
7 EX-101.DEF arg-20210630_def.xml EX-101.DEF 68984
8 EX-101.LAB arg-20210630_lab.xml EX-101.LAB 302861
9 EX-101.PRE arg-20210630_pre.xml EX-101.PRE 205613
10 EXTRACTED XBRL INSTANCE DOCUMENT arg-20210630xex9924b519a_htm.xml XML 655277
Mailing Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 211124683
SIC: 2836 Biological Products, (No Diagnostic Substances)